Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vectors and compositions for treating hemoglobinopathies

Vectors and compositions for treating hemoglobinopathies

US Patent 11261441 · Granted Mar 1, 2022

Estimated economic value: $5,512,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for treating Rac-GTPase mediated disorder2023
Compounds for treating Rac-GTPase mediated disorder2022
Compounds for treating rac-GTPase mediated disorder2020
Targeted therapy to restore radioactive iodine transport in thyroid cancer2019
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2017
Recombinant virus production using mammalian cells in suspension2017
Chimeric peptides for the regulation of GTPases2016
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2015
Methods for enhanced virus-mediated DNA transfer using molecules with virus- and2014
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2014
Chimeric peptides for the regulation of GTPases2014
Chimeric peptides for the regulation of GTPases2012